Biomimetic proteolipid vesicles for targeting inflamed tissues

[1]  Liangfang Zhang,et al.  Cell membrane-camouflaged nanoparticles for drug delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Anna Tampieri,et al.  Evaluation of the osteoinductive potential of a bio-inspired scaffold mimicking the osteogenic niche for bone augmentation. , 2015, Biomaterials.

[3]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[4]  M. Ueda,et al.  Integrin LFA-1 regulates cell adhesion via transient clutch formation. , 2015, Biochemical and biophysical research communications.

[5]  Ronnie H. Fang,et al.  Nanoparticle biointerfacing via platelet membrane cloaking , 2015, Nature.

[6]  E. Tasciotti,et al.  Biodegradable silicon nanoneedles delivering nucleic acids intracellularly induce localized in vivo neovascularization. , 2015, Nature materials.

[7]  E. Tasciotti,et al.  Proteomic Profiling of a Biomimetic Drug Delivery Platform. , 2014, Current drug targets.

[8]  Samir Mitragotri,et al.  Platelet-like Nanoparticles: Mimicking Shape, Flexibility, and Surface Biology of Platelets To Target Vascular Injuries , 2014, ACS nano.

[9]  V. Torchilin Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery , 2014, Nature Reviews Drug Discovery.

[10]  S. Doglia,et al.  A Fourier transform infrared spectroscopy study of cell membrane domain modifications induced by docosahexaenoic acid. , 2014, Biochimica et biophysica acta.

[11]  Ronnie H. Fang,et al.  Clearance of pathological antibodies using biomimetic nanoparticles , 2014, Proceedings of the National Academy of Sciences.

[12]  Brandon S. Brown,et al.  Bromelain Surface Modification Increases the Diffusion of Silica Nanoparticles in the Tumor Extracellular Matrix , 2014, ACS nano.

[13]  Samir Mitragotri,et al.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.

[14]  Rachel A. Kudgus,et al.  Tuning Pharmacokinetics and Biodistribution of a Targeted Drug Delivery System Through Incorporation of a Passive Targeting Component , 2014, Scientific Reports.

[15]  Carmen Alvarez-Lorenzo,et al.  Bioinspired drug delivery systems. , 2013, Current opinion in biotechnology.

[16]  Patrick Couvreur,et al.  Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.

[17]  Marcelle Machluf,et al.  Reconstructed stem cell nanoghosts: a natural tumor targeting platform. , 2013, Nano letters.

[18]  Ronnie H. Fang,et al.  'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach. , 2013, Nanoscale.

[19]  E. Azzopardi,et al.  The enhanced permeability retention effect: a new paradigm for drug targeting in infection. , 2013, The Journal of antimicrobial chemotherapy.

[20]  Hatem Fessi,et al.  Preparation, Characterization and Applications of Liposomes: State of the Art , 2012 .

[21]  C. Veigel,et al.  Effect of Envelope Proteins on the Mechanical Properties of Influenza Virus* , 2012, The Journal of Biological Chemistry.

[22]  Jeffrey W. Smith,et al.  Platelet Mimetic Particles for Targeting Thrombi in Flowing Blood , 2012, Advanced materials.

[23]  D. Paolino,et al.  Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases. , 2012, International journal of pharmaceutics.

[24]  K. Ley,et al.  Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. , 2011, Blood.

[25]  Ildar Khalidov,et al.  Inflamed leukocyte-mimetic nanoparticles for molecular imaging of inflammation. , 2011, Biomaterials.

[26]  D. Irvine,et al.  Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.

[27]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[28]  G. Biggio,et al.  Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[29]  Min Zhang,et al.  Membrane proteomic analysis of pancreatic cancer cells , 2010, Journal of Biomedical Science.

[30]  Gregory P. Robbins,et al.  Tunable leuko-polymersomes that adhere specifically to inflammatory markers. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[31]  S. Mura,et al.  Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. , 2009, International journal of pharmaceutics.

[32]  H. Ditzel,et al.  Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers. , 2009, Journal of proteome research.

[33]  David Piwnica-Worms,et al.  Bioluminescence imaging of myeloperoxidase activity in vivo , 2009, Nature Medicine.

[34]  M. Gorenstein,et al.  The detection, correlation, and comparison of peptide precursor and product ions from data independent LC‐MS with data dependant LC‐MS/MS , 2009, Proteomics.

[35]  Mauro Ferrari,et al.  Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.

[36]  T S Chow,et al.  Nanoscale surface roughness and particle adhesion on structured substrates , 2007 .

[37]  F. Tama,et al.  Removal of Divalent Cations Induces Structural Transitions in Red Clover Necrotic Mosaic Virus, Revealing a Potential Mechanism for RNA Release , 2006, Journal of Virology.

[38]  Ratnesh Lal,et al.  Cisplatin nanoliposomes for cancer therapy: AFM and fluorescence imaging of cisplatin encapsulation, stability, cellular uptake, and toxicity. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[39]  M. Gorenstein,et al.  Quantitative proteomic analysis by accurate mass retention time pairs. , 2005, Analytical chemistry.

[40]  Eberhard Durr,et al.  Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture , 2004, Nature Biotechnology.

[41]  J. M. Lanao,et al.  Drug, enzyme and peptide delivery using erythrocytes as carriers. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[42]  S. Marullo,et al.  Nuclear Functions for Plasma Membrane‐Associated Proteins? , 2003, Traffic.

[43]  D. Franchimont,et al.  Glucocorticoids and Inflammation Revisited: The State of the Art , 2003, Neuroimmunomodulation.

[44]  A. Sigal,et al.  The LFA-1 Integrin Supports Rolling Adhesions on ICAM-1 Under Physiological Shear Flow in a Permissive Cellular Environment1 , 2000, The Journal of Immunology.

[45]  R. Winter,et al.  Interaction of the anticancer agent Taxol (paclitaxel) with phospholipid bilayers. , 1999, Journal of biomedical materials research.

[46]  T. Allen Liposomal Drug Formulations , 1998, Drugs.

[47]  F. Sánchez‐Madrid,et al.  Induction of tyrosine phosphorylation during ICAM-3 and LFA-1-mediated intercellular adhesion, and its regulation by the CD45 tyrosine phosphatase , 1994, The Journal of cell biology.

[48]  T. Harrer,et al.  CD45 mAb induces cell adhesion in peripheral blood mononuclear cells via lymphocyte function-associated antigen-1 (LFA-1) and intercellular cell adhesion molecule 1 (ICAM-1). , 1993, Cellular immunology.

[49]  M. Bretscher Asymmetrical lipid bilayer structure for biological membranes. , 1972, Nature: New biology.

[50]  Anne L. van de Ven,et al.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.

[51]  D. Roberts,et al.  Leukocyte Surface Antigen CD47 , 2013 .

[52]  J. M. Lanao,et al.  Cell-based drug-delivery platforms. , 2012, Therapeutic delivery.

[53]  C. Demetzos Differential Scanning Calorimetry (DSC): a tool to study the thermal behavior of lipid bilayers and liposomal stability. , 2008, Journal of liposome research.

[54]  Markus Voelter,et al.  State of the Art , 1997, Pediatric Research.

[55]  G. Yarrington Molecular Cell Biology , 1987, The Yale Journal of Biology and Medicine.